Atlas Trials

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

Clinical trial NCT00607958 · COMPLETED

Trial details

NCT number
NCT00607958
Sponsor
Germans Trias i Pujol Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2007-12-01
Primary completion
2009-05-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.